Discover

DVA
DaVita Inc.
213.04
300 x 207.05
500 x 220.00
bid
ask
+
2.11
1.00%
400 @ 07:19 PM
213.10 +0.06 (0.03%)
Ytd 87.52%
1y 51.15%
210.94
day range
214.00
101.00
52 week range
215.33
Open 211.60 Prev Close 210.93 Low 210.94 High 214.00 Mkt Cap 13.67B
Vol 493.90K Avg Vol 829.63K EPS 10.38 P/E 20.52 Forward P/E 12.40
Beta 0.91 Short Ratio 4.60 Inst. Own 52.63% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 08-05 50-d Avg 182.70 200-d Avg 143.08 1yr Est 193.71
Earning
Date For Estimate Reported Surprise surprise %
2026-05-05 2026-03 2.41 2.87 0.46 19.09%
2026-02-02 2025-12 3.24 3.4 0.16 4.94%
2025-10-29 2025-09 3.29 2.51 -0.78 -23.71%
2025-08-05 2025-06 2.7 2.95 0.25 9.26%
2025-05-12 2025-03 1.75 2 0.25 14.29%
2025-02-13 2024-12 2.21 2.24 0.03 1.36%
Upgrade / Downgrade
Date Firm Action From To
2026-05-11 TD Cowen Upgrade Hold Hold
2026-05-08 Truist Securities Upgrade Hold Hold
2026-05-08 Barclays Upgrade Equal-Weight Equal-Weight
2026-05-07 UBS Upgrade Buy Buy
2026-05-06 Deutsche Bank Upgrade Hold Buy
2026-02-04 UBS Upgrade Buy Buy
Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Insider Holder
Date Name Relation Quantity Description
2026-05-06 ACKERMAN JOEL Chief Financial Officer 132.43K Sale
2026-05-14 ARWAY PAMELA M. Director 26.95K Stock Award(Grant)
2025-05-14 BERG CHARLES G Director 27.03K Stock Award(Grant)
2026-04-30 BERKSHIRE HATHAWAY, INC. Beneficial Owner of more than 10% of a Class of Security 0.00 Sale
2026-03-12 BERRY CHRISTOPHER MICHAEL Officer 19.64K Stock Award(Grant)
2026-05-14 HEARTY JAMES O Officer 22.39K Sale
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Berkshire Hathaway, Inc 30.10M 6.41B 46.89%
2026-03-30 Blackrock Inc. 2.77M 589.57M 4.31%
2026-03-30 Vanguard Capital Management LLC 2.18M 464.58M 3.40%
2026-03-30 Morgan Stanley 1.67M 355.02M 2.60%
2026-03-30 Vanguard Portfolio Management LLC 1.48M 315.29M 2.30%
2026-03-30 Invesco Ltd. 1.47M 312.79M 2.29%
Fund Ownership
Report Date Organization Position Value Percentage
2026-05-30 Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF 1.09M 231.40M 1.69%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.07M 227.08M 1.66%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 848.58K 180.82M 1.32%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 770.11K 164.10M 1.20%
2026-05-30 NEUBERGER BERMAN EQUITY FUNDS-Neuberger Quality Equity Fund 631.69K 134.61M 0.98%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund 490.42K 104.50M 0.76%
Split
Split Date
2 : 1 2013-09-09
1.5 : 1 2004-06-16
5 : 3 1997-10-21